Entera Bio Ltd.
ENTX
$2.89
$0.020.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.75% | -2.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 28.93% | 16.34% | |||
| Operating Income | -28.93% | -16.34% | |||
| Income Before Tax | -108.62% | -16.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -108.62% | -16.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -108.62% | -16.21% | |||
| EBIT | -28.93% | -16.34% | |||
| EBITDA | -28.94% | -16.38% | |||
| EPS Basic | -97.41% | -15.05% | |||
| Normalized Basic EPS | -97.39% | -15.04% | |||
| EPS Diluted | -97.41% | -15.05% | |||
| Normalized Diluted EPS | -97.39% | -15.04% | |||
| Average Basic Shares Outstanding | 5.64% | 1.02% | |||
| Average Diluted Shares Outstanding | 5.64% | 1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||